Abstract
OBJECTIVE: To determine how many randomized controlled trials on the safety or efficacy of new drugs are published when these drugs are first marketed in Canada, and to determine the quality of the information in those trials. DESIGN: A MEDLINE search was conducted on each drug identified as having novel therapeutic characteristics and first marketed between 1990 and 2000. MAIN OUTCOME MEASURES: Number of trials dealing with the safety or efficacy of each drug published at the time the drug was marketed. Number of patients taking the study drug, length of the trial, and type of control. RESULTS: The number of trials varied substantially. For some drugs, there were more than 20 studies; for others only a single study. Many trials were small and short-term, and used placebo controls. CONCLUSION: Too few trials or inadequate trials on the safety and efficacy of new drugs are published when these drugs are first marketed in Canada. The lack of published trials means that physicians do not know whether results are generalizable to their patients, how to position the drug in relation to other treatments, or whether the drugs have long-term safety and efficacy.
Full Text
The Full Text of this article is available as a PDF (190.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gale E. A. Lessons from the glitazones: a story of drug development. Lancet. 2001 Jun 9;357(9271):1870–1875. doi: 10.1016/S0140-6736(00)04960-6. [DOI] [PubMed] [Google Scholar]
- Lexchin J. Secrecy and the health protection branch. CMAJ. 1998 Sep 8;159(5):481–483. [PMC free article] [PubMed] [Google Scholar]
- Melzer D. New drug treatment for Alzheimer's disease: lessons for healthcare policy. BMJ. 1998 Mar 7;316(7133):762–764. doi: 10.1136/bmj.316.7133.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pocock S. J., Elbourne D. R. Randomized trials or observational tribulations? N Engl J Med. 2000 Jun 22;342(25):1907–1909. doi: 10.1056/NEJM200006223422511. [DOI] [PubMed] [Google Scholar]
- Wilkes M. S., Doblin B. H., Shapiro M. F. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992 Jun 1;116(11):912–919. doi: 10.7326/0003-4819-116-11-912. [DOI] [PubMed] [Google Scholar]